Pallliative care, pain, geriatrics, mental health
McGill University department of Family Medicine
Dr. Cyr has been practicing family medicine in Quebec since 1996. He is a Faculty Lecturer in the Department of Family Medicine at McGill University and participated as an Associate Researcher for the Quebec Cannabis Registry, the world’s first research database on the use of cannabis for medical purposes.
He completed his Family Medicine Residency at Laval University in Quebec city. His major clinical interests are in pain management, geriatrics, mental health and the use of cannabinoid based medicines in palliative and cancer care. He is the founder of Doctors for Responsible Access, an association of medical cannabis practitioners whose mission was to support responsible access to cannabis in light of legalization in Canada. His focus is on the conception and dissemination of judicious educational tools for Health Care Providers interested in the use of cannabinoid based medicines. He is a recognized cannabis educator and government advisor and is actively involved in supporting the role of pharmacists in having a primary role as medical cannabis providers in Quebec. He is a member of the Society of Cannabis Clinicians, the Canadian Consortium for the Investigations of Cannabinoids and member of Drug Free Kids Canada’s advisory council.
Cyr C, Davis M, Schecter D, Daeninck P (2022) Cannabis and Cannabinoid-Based Medicines in Cancer Care, 1st ed. Springer International Publishing
Cyr C, Arboleda MF, Aggarwal SK, Balneaves LG, Daeninck P, Néron A, Prosk E, Vigano A (2018) Cannabis in palliative care: current challenges and practical recommendations. Ann Palliat Med 7:463–477
Sihota A, Smith BK, Ahmed S-A, et al (2021) Consensus-based recommendations for titrating cannabinoids and tapering opioids for chronic pain control. International Journal of Clinical Practice 75:e13871
Bhaskar A, Bell A, Boivin M, et al (2021) Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process. J Cannabis Res 3:22
Gottschling S, Ayonrinde O, Bhaskar A, Blockman M, D’Agnone O, Schecter D, Suárez Rodríguez LD, Yafai S, Cyr C (2020) Safety Considerations in Cannabinoid-Based Medicine. Int J Gen Med 13:1317–1333